Bioactive Compounds From Microalgae: Current Development and Prospects

W. Fu, David Nelson, Z. Yi, M. Xu, B. Khraiwesh, K. Jijakli, A. Chaiboonchoe, A. Alzahmi, D. Al-Khairy, S. Brynjolfsson, Kourosh Salehi-Ashtiani

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Microalgae make up the largest and likely most diverse group of photosynthetic organisms in freshwater and marine systems. As new technologies are emerging for the study of bioactive compounds from microalgae, this group is drawing attention as a promising source of natural products that have wide applications in the food and pharmaceutical industries. Algae-derived bioactive compounds are attractive resources for drug screening, given their tremendous structural diversity and biological availability. In this chapter, we first discuss medicinally important products, such as carotenoids, including β-carotene, fucoxanthin, astaxanthin, and lutein, as well as essential fatty acids that originate in microalgae. We then briefly introduce screening assays for antioxidant, antimicrobial, antiviral, anticancer, and immunomodulatory effects, and explore biosynthesis of natural products, which have been widely used in food and cosmetics for their antioxidant effects and nutritional value, and we discuss the potential use of fucoxanthin and its derivatives as anticancer agents. In addition, we describe health benefits of the essential fatty acids eicosapentaenoic acid and docosahexaenoic acid. Further, this chapter emphasizes that microalgae provide a rich source of compounds for therapeutic drug screening and describes examples of screening assays for detection of biological activities of algae-derived compounds.

Original languageEnglish (US)
Title of host publicationStudies in Natural Products Chemistry
PublisherElsevier B.V.
Pages199-225
Number of pages27
DOIs
StatePublished - Jan 1 2017

Publication series

NameStudies in Natural Products Chemistry
Volume54
ISSN (Print)1572-5995

Fingerprint

Microalgae
Screening
Essential Fatty Acids
Preclinical Drug Evaluations
Carotenoids
Algae
Biological Products
Assays
Antioxidants
Pharmaceutical Preparations
Lutein
Eicosapentaenoic Acid
Cosmetics
Docosahexaenoic Acids
Food Industry
Biosynthesis
Nutritive Value
Drug Industry
Insurance Benefits
Bioactivity

Keywords

  • Bioactivities
  • Biological assays
  • Carotenoids
  • Essential fatty acids
  • Green algae and diatoms

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry

Cite this

Fu, W., Nelson, D., Yi, Z., Xu, M., Khraiwesh, B., Jijakli, K., ... Salehi-Ashtiani, K. (2017). Bioactive Compounds From Microalgae: Current Development and Prospects. In Studies in Natural Products Chemistry (pp. 199-225). (Studies in Natural Products Chemistry; Vol. 54). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-63929-5.00006-1

Bioactive Compounds From Microalgae : Current Development and Prospects. / Fu, W.; Nelson, David; Yi, Z.; Xu, M.; Khraiwesh, B.; Jijakli, K.; Chaiboonchoe, A.; Alzahmi, A.; Al-Khairy, D.; Brynjolfsson, S.; Salehi-Ashtiani, Kourosh.

Studies in Natural Products Chemistry. Elsevier B.V., 2017. p. 199-225 (Studies in Natural Products Chemistry; Vol. 54).

Research output: Chapter in Book/Report/Conference proceedingChapter

Fu, W, Nelson, D, Yi, Z, Xu, M, Khraiwesh, B, Jijakli, K, Chaiboonchoe, A, Alzahmi, A, Al-Khairy, D, Brynjolfsson, S & Salehi-Ashtiani, K 2017, Bioactive Compounds From Microalgae: Current Development and Prospects. in Studies in Natural Products Chemistry. Studies in Natural Products Chemistry, vol. 54, Elsevier B.V., pp. 199-225. https://doi.org/10.1016/B978-0-444-63929-5.00006-1
Fu W, Nelson D, Yi Z, Xu M, Khraiwesh B, Jijakli K et al. Bioactive Compounds From Microalgae: Current Development and Prospects. In Studies in Natural Products Chemistry. Elsevier B.V. 2017. p. 199-225. (Studies in Natural Products Chemistry). https://doi.org/10.1016/B978-0-444-63929-5.00006-1
Fu, W. ; Nelson, David ; Yi, Z. ; Xu, M. ; Khraiwesh, B. ; Jijakli, K. ; Chaiboonchoe, A. ; Alzahmi, A. ; Al-Khairy, D. ; Brynjolfsson, S. ; Salehi-Ashtiani, Kourosh. / Bioactive Compounds From Microalgae : Current Development and Prospects. Studies in Natural Products Chemistry. Elsevier B.V., 2017. pp. 199-225 (Studies in Natural Products Chemistry).
@inbook{f3422bc46cf6455895925eb8fe5b8df2,
title = "Bioactive Compounds From Microalgae: Current Development and Prospects",
abstract = "Microalgae make up the largest and likely most diverse group of photosynthetic organisms in freshwater and marine systems. As new technologies are emerging for the study of bioactive compounds from microalgae, this group is drawing attention as a promising source of natural products that have wide applications in the food and pharmaceutical industries. Algae-derived bioactive compounds are attractive resources for drug screening, given their tremendous structural diversity and biological availability. In this chapter, we first discuss medicinally important products, such as carotenoids, including β-carotene, fucoxanthin, astaxanthin, and lutein, as well as essential fatty acids that originate in microalgae. We then briefly introduce screening assays for antioxidant, antimicrobial, antiviral, anticancer, and immunomodulatory effects, and explore biosynthesis of natural products, which have been widely used in food and cosmetics for their antioxidant effects and nutritional value, and we discuss the potential use of fucoxanthin and its derivatives as anticancer agents. In addition, we describe health benefits of the essential fatty acids eicosapentaenoic acid and docosahexaenoic acid. Further, this chapter emphasizes that microalgae provide a rich source of compounds for therapeutic drug screening and describes examples of screening assays for detection of biological activities of algae-derived compounds.",
keywords = "Bioactivities, Biological assays, Carotenoids, Essential fatty acids, Green algae and diatoms",
author = "W. Fu and David Nelson and Z. Yi and M. Xu and B. Khraiwesh and K. Jijakli and A. Chaiboonchoe and A. Alzahmi and D. Al-Khairy and S. Brynjolfsson and Kourosh Salehi-Ashtiani",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/B978-0-444-63929-5.00006-1",
language = "English (US)",
series = "Studies in Natural Products Chemistry",
publisher = "Elsevier B.V.",
pages = "199--225",
booktitle = "Studies in Natural Products Chemistry",

}

TY - CHAP

T1 - Bioactive Compounds From Microalgae

T2 - Current Development and Prospects

AU - Fu, W.

AU - Nelson, David

AU - Yi, Z.

AU - Xu, M.

AU - Khraiwesh, B.

AU - Jijakli, K.

AU - Chaiboonchoe, A.

AU - Alzahmi, A.

AU - Al-Khairy, D.

AU - Brynjolfsson, S.

AU - Salehi-Ashtiani, Kourosh

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Microalgae make up the largest and likely most diverse group of photosynthetic organisms in freshwater and marine systems. As new technologies are emerging for the study of bioactive compounds from microalgae, this group is drawing attention as a promising source of natural products that have wide applications in the food and pharmaceutical industries. Algae-derived bioactive compounds are attractive resources for drug screening, given their tremendous structural diversity and biological availability. In this chapter, we first discuss medicinally important products, such as carotenoids, including β-carotene, fucoxanthin, astaxanthin, and lutein, as well as essential fatty acids that originate in microalgae. We then briefly introduce screening assays for antioxidant, antimicrobial, antiviral, anticancer, and immunomodulatory effects, and explore biosynthesis of natural products, which have been widely used in food and cosmetics for their antioxidant effects and nutritional value, and we discuss the potential use of fucoxanthin and its derivatives as anticancer agents. In addition, we describe health benefits of the essential fatty acids eicosapentaenoic acid and docosahexaenoic acid. Further, this chapter emphasizes that microalgae provide a rich source of compounds for therapeutic drug screening and describes examples of screening assays for detection of biological activities of algae-derived compounds.

AB - Microalgae make up the largest and likely most diverse group of photosynthetic organisms in freshwater and marine systems. As new technologies are emerging for the study of bioactive compounds from microalgae, this group is drawing attention as a promising source of natural products that have wide applications in the food and pharmaceutical industries. Algae-derived bioactive compounds are attractive resources for drug screening, given their tremendous structural diversity and biological availability. In this chapter, we first discuss medicinally important products, such as carotenoids, including β-carotene, fucoxanthin, astaxanthin, and lutein, as well as essential fatty acids that originate in microalgae. We then briefly introduce screening assays for antioxidant, antimicrobial, antiviral, anticancer, and immunomodulatory effects, and explore biosynthesis of natural products, which have been widely used in food and cosmetics for their antioxidant effects and nutritional value, and we discuss the potential use of fucoxanthin and its derivatives as anticancer agents. In addition, we describe health benefits of the essential fatty acids eicosapentaenoic acid and docosahexaenoic acid. Further, this chapter emphasizes that microalgae provide a rich source of compounds for therapeutic drug screening and describes examples of screening assays for detection of biological activities of algae-derived compounds.

KW - Bioactivities

KW - Biological assays

KW - Carotenoids

KW - Essential fatty acids

KW - Green algae and diatoms

UR - http://www.scopus.com/inward/record.url?scp=85029546728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029546728&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-63929-5.00006-1

DO - 10.1016/B978-0-444-63929-5.00006-1

M3 - Chapter

AN - SCOPUS:85029546728

T3 - Studies in Natural Products Chemistry

SP - 199

EP - 225

BT - Studies in Natural Products Chemistry

PB - Elsevier B.V.

ER -